CAS No.100286-90-6 Irinotecan hydrochloride Pharmaceutical Intermediates
Product detail
product detail
|
CAS No. |
40856-44-8 |
|
EINECS |
609-874-3 |
|
Formula |
C9H11NO2 |
|
Molecular Weight |
165.19 |
|
Appearance |
White to Off-White solid |
|
Purity |
≥98% |
|
Type |
Pharmaceutical Intermediates |
1. Cancer treatment efficacy: Irinotecan hydrochloride has shown significant clinical efficacy in the treatment of advanced colorectal cancer, especially when used in combination with other chemotherapy drugs. Its ability to target and inhibit topoisomerase I makes it a powerful weapon for oncologists.
2. Widely Used: In addition to colorectal cancer, irinotecan hydrochloride is also effective in treating other malignancies, including small cell lung cancer and certain types of ovarian cancer. This use makes it a valuable addition to any cancer treatment regimen.
3. Proven safety: A large number of clinical studies have confirmed the safety and tolerability of irinotecan hydrochloride. Although side effects may occur, these side effects are generally controllable and patients can continue treatment without much disruption.
4. High Purity and Quality: Our manufacturing process follows strict quality control measures to ensure that our irinotecan hydrochloride is of the highest purity. This commitment to quality translates into better patient outcomes and greater trust from healthcare providers.
5. Competitive prices and supply chain efficiency: As a factory integrating production and trading, we can offer competitive prices without compromising quality. Our efficient supply chain ensures that our customers receive their orders in a timely manner, thus meeting the needs of patients and medical institutions.



